ASHLEY SIMO: Open Payments
NPI 1316709140 · AUBREY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$768 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $285 · 2025 $768
Food & beverage: $768
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $390 |
| ABBVIE INC. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $119 |
| TerSera Therapeutics LLC | 2 | $44 |
| Lilly USA, LLC | 1 | $27 |
| Lundbeck LLC | 1 | $26 |
| ARGENX US, INC. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: KRYSTEXXA, SKYRIZI, FASENRA, EVENITY, Quzyttir, KISUNLA, VYEPTI, VYVGART HYTRULO.
Industry payments across TX — which companies pay providers there.
